YKL-40 concentrations are not elevated in gestational diabetes

European Journal of Clinical Investigation

Volumn 40, Issue 4, 2010, Pages 339-343

  Schaller, Georg ^a   Brix, Johanna Maria ^a   Placher Sorko, Gudrun ^a   Höllerl, Florian ^a   Schernthaner, Gerit Holger ^b   Schernthaner, Guntram ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gestational diabetes; Inflammation; YKL 40

Indexed keywords

GLUCOSE; GLYCOPROTEIN; INSULIN; UNCLASSIFIED DRUG; YKL 40;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; LECTINS; PREGNANCY;

EID: 77949737973     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02274.x     Document Type: Article

References (26)

1. Reece EA, Leguizamón G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009 373 : 1789 1797.
2. Gestational diabetes mellitus. Diabetes Care 2004 27 (Suppl. 1 S88 90.
3. Yogev Y, Visser GH. Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med 2009 14 : 77 84.
4. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005 115 : 1111 1119.
5. de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008 582 : 97 105.
6. Noussitou P, Monbaron D, Vial Y, Gaillard RC, Ruiz J. Gestational diabetes mellitus and the risk of metabolic syndrome: a population-based study in Lausanne, Switzerland. Diabetes Metab 2005 31 : 361 369.
7. Bo S, Signorile A, Menato G, Gambino R, Bardelli C, Gallo ML et al. C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest 2005 28 : 779 786.
8. Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004 27 : 1721 1727.
9. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003 26 : 819 824.
10. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002 51 : 2207 2213.
11. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003 88 : 3507 3512.
12. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993 268 : 25803 25810.
13. Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 1992 7 : 501 512.
14. Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006 55 : 221 227.
15. Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, Aerts JM et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999 19 : 687 694.
16. Wang Y, Ripa RS, Johansen JS, Gabrielsen A, Steinbrüchel DA, Friis T et al. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J 2008 42 : 295 302.
17. Nielsen AR, Erikstrup C, Johansen JS, Fischer CP, Plomgaard P, Krogh-Madsen R et al. Plasma YKL-40: a BMI-independent marker of type 2 diabetes. Diabetes 2008 57 : 3078 3082.
18. Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 2009 32 : 323 328.
19. Klein K, Satler M, Elhenicky M, Brix J, Krzyzanowska K, Schernthaner G et al. Circulating levels of MCP-1 are increased in women with gestational diabetes. Prenat Diagn 2008 28 : 845 851.
20. Madazli R, Kucur M, Gezer A, Isman F, Bulut B. Chitotriosidase and YKL-40 in normal and pre-eclamptic pregnancies. Int J Gynaecol Obstet 2008 100 : 239 243.
21. Seol HJ, Lee ES, Jung SE, Jeong NH, Lim JE, Park SH et al. Serum levels of YKL-40 and interleukin-18 and their relationship to disease severity in patients with preeclampsia. J Reprod Immunol 2009 79 : 183 187.
22. Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 2006 55 : 53 9.
23. Kucur M, Isman FK, Karadag B, Vural VA, Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 2007 18 : 391 396.
24. Johansen JS, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK, Bruunsgaard H. High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin Exp Immunol 2008 151 : 260 266.
25. Friedman JE, Kirwan JP, Jing M, Presley L, Catalano PM. Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes 2008 57 : 606 613.
26. Nøjgaard C, Host NB, Christensen IJ, Poulsen SH, Egstrup K, Price PA et al. Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 2008 19 : 257 263.